Temodar and Temaz drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Temodar (temozolomide) and Temaz (temazepam). Common drug interactions include death among females and thrombocytopenia among males.

The phase IV clinical study analyzes what interactions people have when they take Temodar and Temaz. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Temodar?

Temodar has active ingredients of temozolomide. It is often used in glioblastoma multiforme. eHealthMe is studying from 6,683 Temodar users. Check the latest studies of Temodar.

What is Temaz?

Temaz has active ingredients of temazepam. It is often used in insomnia. eHealthMe is studying from 42,293 Temaz users. Check the latest studies of Temaz.

On Jul, 14, 2026

13 people who take Temodar and Temaz together, and have interactions are studied.

What are the common drug interactions of Temodar and Temaz, by gender? *:

female:

Death
Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
Diarrhoea
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Infection

male:

Thrombocytopenia (decrease of platelets in blood)
Febrile neutropenia (fever with reduced white blood cells)
Sinus disorder (disease of sinus)
Streptococcal infection
Alanine aminotransferase increased
Aspartate aminotransferase increased
Blood alkaline phosphatase increased
Catheter related complication
Confusional state
Convulsions (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled of muscles contract and relax rapidly and repeatedly)

What are the common drug interactions of Temodar and Temaz, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Thrombocytopenia (decrease of platelets in blood)
Malignant neoplasm progression (cancer tumour came back)
Brain abscess
Dysphagia (a condition in which swallowing is difficult or painful)
Febrile neutropenia (fever with reduced white blood cells)
Immunosuppression
Nausea (feeling of having an urge to vomit)
Neutropenia (an abnormally low number of neutrophils)
Pneumonia
Pyrexia (fever)

60+:

Death
Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
Intestinal obstruction
Neoplasm malignant (cancer tumour)
Vomiting
Diarrhoea
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Infection
Confusional state
Cystitis (inflammation of the wall of the bladder)

What are the existing conditions these people have? *

Glioblastoma (most common and most aggressive malignant primary brain tumour in humans): 7 people, 53.85%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 3 people, 23.08%
Migraine (headache): 3 people, 23.08%
High Blood Pressure: 3 people, 23.08%
Depression: 3 people, 23.08%
Brain Oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain): 3 people, 23.08%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 1 person, 7.69%
Stomatitis (inflammation of mucous membrane of mouth): 1 person, 7.69%
Pain: 1 person, 7.69%
Nausea (feeling of having an urge to vomit): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Temodar and Temaz?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously